Latanoprostene Bunod Ophthalmic Solution, 0.024% Solution/ Drops
Product Images NDC 68083-563
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Latanoprostene Bunod Ophthalmic Solution, 0.024% (NDC 68083-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Bottle-label-5ml (Bottle Label 5ml)
This is a description for a medication called Latanoprostene Bunod Ophthalmic Solution. The recommended storage instructions are to keep the unopened bottle refrigerated at 2° to 8°C [36° to 46°F]. Once opened, it can be stored at 2° to 25 [36° to 77°F] for up to 8 weeks. The product should be protected from light and freezing to maintain its effectiveness. The National Drug Code (NDC) for this medication is 68083-564-01. It is manufactured by Gland Pharma Limited in Hyderabad, India. This solution is indicated for eye use only and is sterile. The usual dosage information should be consulted in the package insert.*
Carton-label-2-5ml (Carton Label 2 5ml)
Carton-label-5ml (Carton Label 5ml)
Latanoprostene-bunod-spl-structure (Latanoprostene Bunod Spl Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.